Latest News

Key brain signaling mechanism for rapidly acting antidepressants

Two years ago, mammalian target of rapamycin or mTOR, a signaling protein, was identified as a key mediator of the antidepressant effects of ketamine, the first rapidly acting antidepressant medication to be identified.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Retinoids may increase effectiveness of targeted therapies against high-risk leukemia

  • Air pollution linked to children's low academic achievement

  • Turning breath into words: New device unveiled to give paralysis victims a voice

  • Neurobiology: Light-activated learning

  • Glial cells use lipids to direct neuron organization in the spinal cord

  • Degenerating neurons respond to gene therapy treatment for Alzheimer's disease

  • Massive study reports challenges in reproducing published psychology findings

  • Four-day school week can improve academic performance, study finds

  • Cannabis and the brain

  • Awareness of memory loss may decline two-three years before dementia onset

  •